The U.S. Drug Enforcement Administration will recommend that marijuana should be rescheduled from a Schedule I drug to a Schedule III drug, according to an announcement made April 30, 2024 by the U.S.
Forbes contributors publish independent expert analyses and insights. Alonzo Martinez reports on employment laws and trends in HR tech. This voice experience is generated by AI. Learn more. This voice ...
It doesn’t routinely test generics for quality concerns or to see if they’re working as effectively as brand-name medications. Instead, the agency heavily relies on drug companies, often in countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results